STERIS Announces Disinfectant Claims for CIP 200™ Acid-Based Cleaner and Disinfectant

STERIS announces the addition of disinfection and virucidal activity claims in the United States for CIP 200™ Acid-Based Cleaner and Disinfectant. The new label claims are the result of extensive testing and development.

CIP 200 Acid-Based Cleaner and Disinfectant has received the following biocidal claims on washable, hard, nonporous surfaces in the presence of 5% organic soil (serum) when used at a 1% concentration of product:

• Staphylococcus aureus (ATCC 6538) in 10 minutes at or above 60 °C.
• Pseudomonas aeruginosa (ATCC 15442) in 10 minutes at or above 60 °C.

Additionally, CIP 200 Acid-Based Cleaner and Disinfectant is effective against Bovine Viral Diarrhea Virus (BVDV) when used at a 1% concentration of product per gallon of deionized water in 5% blood serum at 60°C for a contact time of 10 minutes.

CIP 200 Acid-Based Cleaner and Disinfectant is available in the United States beginning in January 2021. CIP 200 Acid-Based Process and Research Cleaner will continue to be available globally. For US-based Customer’s currently using CIP 200 Acid-Based Process and Research Cleaner, the transition to CIP 200 Acid-Based Cleaner and Disinfectant does not impact the formulation of the product and will not require requalification or revalidation.

STERIS continues to meet our Customers’ validation objectives and quality needs with innovative product claims, an extensive documentation package, and support from the STERIS Technical Services team.

STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life sciences products and services around the globe.

This news release may contain statements concerning certain expectations, forecasts, estimates, product performance or other forward-looking information affecting or relating to the Company or its products that are intended to qualify for the protections afforded "forward- looking statements" under the Private Securities Litigation Reform Act of 1995 and other laws and regulations. Forward-looking statements speak only as to the date of this report, and may be identified by the use of forward-looking terms such as "may," "will," "expects," "believes," "anticipates," "plans," “new,” “advanced,” and “best available,” or the negative of such terms or other variations on such terms or comparable terminology. Many important factors could cause actual results to differ materially from those in this news release including, without limitation, disruption of production or supplies, changes in product use, pending or future claims, technology advances, and changes in government regulations or the application or interpretation thereof. No assurances can be provided as to any product performance or product safety unless all labeling, instructions for use, SDS and other product literature are strictly followed. Unless legally required, the Company does not undertake to update or revise any forward-looking statements even if events make clear that any projected results, express or implied, will not be realized. Other potential risks and uncertainties that could cause actual results to differ materially from those in this news release include, without limitation, (a) the possibility that market demand will not develop for new technologies, products or application; (b) the possibility that application of or compliance with laws, court rulings, regulations, certifications or other requirements or standards may delay or prevent product introductions, affect the production and marketing of existing products, or otherwise affect product performance; or (c)uses not consistent with product instructions. Product descriptions and performances herein are for illustration only and do not modify labeling, warranties or other technical literature.